These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 2480283

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Graft-versus-leukemia activity after T-cell depletion using counterflow centrifugation.
    de Witte T, Preijers F, Schattenberg A.
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():103-5. PubMed ID: 2202463
    [No Abstract] [Full Text] [Related]

  • 7. Effector cells of graft-versus-host disease, host resistance, and the graft-versus-leukemia effect: summary of a workshop on bone marrow transplantation.
    Ringdén O, Deeg HJ, Beschorner W, Slavin S.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2758-61. PubMed ID: 3547953
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Prevention of graft-versus-host disease following allogeneic bone marrow transplantation by removal of T-cells].
    de Gast GC, Verdonck LF, van Kempen-Harteveld ML, Gerritsen H, Dekker AW.
    Ned Tijdschr Geneeskd; 1986 May 10; 130(19):868-71. PubMed ID: 3520348
    [No Abstract] [Full Text] [Related]

  • 11. Bone marrow transplantation for leukemia: effects of T lymphocyte depletion of donor bone marrow.
    Champlin R.
    Transplant Proc; 1987 Feb 10; 19(1 Pt 1):157-9. PubMed ID: 3274769
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Prevention of graft versus host disease by in vitro immunodepletion of the graft].
    Maraninchi D.
    Nouv Rev Fr Hematol (1978); 1985 Feb 10; 27(6):349-50. PubMed ID: 3912729
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. T cell depletion in bone marrow transplantation for leukemia: current results and future directions.
    Butturini A, Gale RP.
    Bone Marrow Transplant; 1988 May 10; 3(3):185-92. PubMed ID: 3048485
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Graft versus host disease in children: the AIEOP BMT group experience.
    Porta F, Nespoli L, Uderzo C, Conter V, Miniero R, Arcese W, Dini G, Colleselli P, Bagnulo S, Andolina M.
    Bone Marrow Transplant; 1989 Dec 10; 4 Suppl 4():149-50. PubMed ID: 2627617
    [No Abstract] [Full Text] [Related]

  • 19. [Graft-versus-host disease].
    Svedentsov EP, Sharygin SL, Epifanov NS, Matveev GA.
    Klin Med (Mosk); 1993 Dec 10; 71(5):19-23. PubMed ID: 8301977
    [No Abstract] [Full Text] [Related]

  • 20. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM, Omdal BK, Dai KZ, Martens A, Benestad HB, Vaage JT, Rolstad B.
    Transplantation; 2008 Jan 15; 85(1):102-11. PubMed ID: 18192919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.